Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| ABC transporters | R-HSA-1369007 | map02010 | metanephrine | 21100 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | metolazone | 36119 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | metolazone | 36119 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | metolazone | 36119 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | metolazone | 36119 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | metolazone | 36119 | drug-path |
| Notch signaling pathway | R-HSA-157118 | map04330 | metolazone | 36119 | drug-path |
| mTOR signaling pathway | R-HSA-165662 | map04150 | metolazone | 36119 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | dipyridamole | 3108 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | dipyridamole | 3108 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | dipyridamole | 3108 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | dipyridamole | 3108 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | dipyridamole | 3108 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | dipyridamole | 3108 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | dipyridamole | 3108 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | dipyridamole | 3108 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | loxapine | 3964 | drug-path |
| Notch signaling pathway | R-HSA-157118 | map04330 | loxapine | 3964 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | propranolol | 4946 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | propranolol | 4946 | drug-path |